Tuesday, July 22, 2008 11:50:07 AM
The current float is a shade under 175 million. An authorised float of 800 million represents dilution of 357%.
Another way of expressing this is that if the fair value of a Biophan share is 1.5 cents today, if all these extra shares are issued, it should be worth 0.32 cents, or less than half a cent, all other things being equal.
The increase in float over the past few months has shown that Biophan is not afraid to use its authorised shares, even though it's a cruel and unusual punishment to inflict upon its long suffering shareholders.
And again, with all that Medtronic money, I fail to see why they should need to dilute - or MegaDilute, more accurately.
Unless they positively want to feed their pet rat to make him or her big, sleek and glossy of course. But why should they want to do that, I wonder?
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM